Table 4.
Screening strategy | TP | TN | FN | FP | N | Exclusion rate |
Sens | Spec | LR(-) | Posterior Probability |
FN with Subseg* |
CIN** |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Site D-dimer, standard threshold* | 35 | 39 | 1 | 211 | 286 | 6% | 97.2% | 15.6% | 0.18 | 2.5% | 0 | 0 |
D-dimer < 500 ng/mL | 118 | 144 | 8 | 408 | 678 | 22% | 93.7% | 26.1% | 0.24 | 5.3% | 7 | 3 |
D-dimer < 1000 ng/mL | 105 | 289 | 21 | 263 | 678 | 46% | 83.3% | 52.4% | 0.32 | 6.8% | 17 | 11 |
D-dimer < 500 or <1000 if Age >70 | 116 | 175 | 10 | 377 | 678 | 27% | 92.1% | 31.7% | 0.25 | 5.4% | 9 | 6 |
Wells ≤4 and D-dimer <500 ng/mL | 122 | 102 | 4 | 450 | 678 | 16% | 96.8% | 18.5% | 0.17 | 3.8% | 4 | 2 |
Wells≤4 and D-dimer <1000 ng/mL | 114 | 209 | 12 | 343 | 678 | 33% | 90.5% | 37.9% | 0.25 | 5.4% | 10 | 10 |
RGS≤6 and D-dimer <500 ng/mL | 122 | 106 | 4 | 446 | 678 | 16% | 96.8% | 19.2% | 0.17 | 3.6% | 4 | 2 |
RGS≤6 and D-dimer <1000 ng/mL | 115 | 197 | 11 | 355 | 678 | 31% | 91.3% | 35.7% | 0.24 | 5.3% | 10 | 9 |
Abbreviations: TP- true positive, TN- true negative, FN false negative, FP- false positive, Sens sensitivity, Spec- specificity, LR(-)- likelihood ratio negative, DVT- deep venous thrombosis, CIN- contrast induced nephropathy (defined as a 50% increase in serum creatinine within 2–7 days), RGS-revised Geneva score
number of false negative PEs that were subsegmental;
number of cases of contrast induced nephropathy in the true negative group